Articlegreen2004

Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry

971 citations0/0 files storedThe Quarterly Journal of Economics

No readable copy stored yet — this record is metadata only.

Pharmaceutical Economics and Policy Intellectual Property and Patents Firm Innovation and Growth

Abstract

This paper investigates the effect of (potential) market size on entry of new drugs and pharmaceutical innovation. Focusing on exogenous changes driven by U. S. demographic trends, we find a large effect of potential market size on the entry of nongeneric drugs and new molecular entities. These effects are generally robust to controlling for a variety of supply-side factors and changes in the technology of pharmaceutical research.

Citations in this library

Stored only when both papers are in the corpus — 971 citations exist upstream.

References

2001Econometric Analysis of Cross Section and Panel Data 1998Initial conditions and moment restrictions in dynamic panel data models 1995Another look at the instrumental variable estimation of error-components models 1990Endogenous Technological Change 1995Initial conditions and moment restrictions in dynamic panel data models 1989Endogenous Technological Change 1992A Model of Growth Through Creative Destruction 1962The Economic Implications of Learning by Doing

Cited by

2010Fifty Years of Empirical Studies of Innovative Activity and Performance 2011The productivity crisis in pharmaceutical R&D 2021Why Working from Home Will Stick 2010The Supply Side of Innovation: H‐1B Visa Reforms and U.S. Ethnic Invention 2008INNOVATION AND COMPETITIVE PRESSURE*2019Shift-Share Designs: Theory and Inference*2015Contribution of air conditioning adoption to future energy use under global warming

Imported from OpenAlex (CC0) — nothing here is generated.